16-23680095-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005030.6(PLK1):c.420G>A(p.Glu140=) variant causes a synonymous change. The variant allele was found at a frequency of 0.0021 in 1,613,614 control chromosomes in the GnomAD database, including 59 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 29 hom., cov: 31)
Exomes 𝑓: 0.0012 ( 30 hom. )
Consequence
PLK1
NM_005030.6 synonymous
NM_005030.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.69
Genes affected
PLK1 (HGNC:9077): (polo like kinase 1) The Ser/Thr protein kinase encoded by this gene belongs to the CDC5/Polo subfamily. It is highly expressed during mitosis and elevated levels are found in many different types of cancer. Depletion of this protein in cancer cells dramatically inhibited cell proliferation and induced apoptosis; hence, it is a target for cancer therapy. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 16-23680095-G-A is Benign according to our data. Variant chr16-23680095-G-A is described in ClinVar as [Benign]. Clinvar id is 791333.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.011 (1677/152092) while in subpopulation AFR AF= 0.0384 (1594/41462). AF 95% confidence interval is 0.0369. There are 29 homozygotes in gnomad4. There are 808 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1677 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLK1 | NM_005030.6 | c.420G>A | p.Glu140= | synonymous_variant | 2/10 | ENST00000300093.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLK1 | ENST00000300093.9 | c.420G>A | p.Glu140= | synonymous_variant | 2/10 | 1 | NM_005030.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0110 AC: 1671AN: 151974Hom.: 30 Cov.: 31
GnomAD3 genomes
AF:
AC:
1671
AN:
151974
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00289 AC: 726AN: 250944Hom.: 9 AF XY: 0.00243 AC XY: 329AN XY: 135638
GnomAD3 exomes
AF:
AC:
726
AN:
250944
Hom.:
AF XY:
AC XY:
329
AN XY:
135638
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00117 AC: 1716AN: 1461522Hom.: 30 Cov.: 30 AF XY: 0.00104 AC XY: 754AN XY: 727078
GnomAD4 exome
AF:
AC:
1716
AN:
1461522
Hom.:
Cov.:
30
AF XY:
AC XY:
754
AN XY:
727078
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0110 AC: 1677AN: 152092Hom.: 29 Cov.: 31 AF XY: 0.0109 AC XY: 808AN XY: 74360
GnomAD4 genome
AF:
AC:
1677
AN:
152092
Hom.:
Cov.:
31
AF XY:
AC XY:
808
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at